Sodium Chloride Injection, Solution
Product Images NDC 0338-9793

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sodium Chloride (NDC 0338-9793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dhcp Letter 1.jpg (Image 01)

This document from Baxter Healthcare Corporation provides important prescribing information regarding the temporary importation of 0.9% Sodium Chloride Injection and related glucose injection products due to drug shortages. It includes a table listing product names, sizes, product codes, bags per carton, and NDC codes for each imported product. Additional instructions emphasize inspecting bags for defects before use.*

FDA Label Image

Dhcp Letter 2.jpg (Image 02)

This text document outlines compatibility, labeling, and formulation differences between FDA-approved and imported 0.9% Sodium Chloride and various Dextrose injection products. It includes details on barcode placement, packaging, energy content per milliliter comparisons for glucose and sodium chloride solutions, and advisories on non-interchangeability of certain glucose-containing injections. The document references multiple tables summarizing key differences in labeling and product specifications.*

FDA Label Image

Dhcp Letter 3.jpg (Image 03)

A text document page providing instructions for reporting adverse events or product quality issues related to imported Baxter Healthcare products, including Sodium Chloride Injection. It includes contact phone numbers, fax numbers, online report links, and references to FDA-approved prescribing information and local prescribing information in English. The page also offers contact details for Baxter's Medical Information Service and order placement.*

FDA Label Image

Dhcp Letter 4.jpg (Image 04)

A product comparison table detailing differences between FDA-approved and imported 0.9% Sodium Chloride Injection USP. The table covers product name, label volume, language of labels, indications, active ingredients, additional information, storage conditions, container type, and medication and administration port closures with images of each port type.*

FDA Label Image

Dhcp Letter 5.jpg (Image 05)

Label images for FDA-approved and imported 0.9% Sodium Chloride Injection USP 1000 mL. The left side shows the FDA-approved product label with black text indicating 0.9% Sodium Chloride Injection USP, 1000 mL volume, manufacturer Baxter Healthcare Corporation, and detailed product information including dosage and storage instructions. The right side shows the imported product label from Shanghai, China, with similar 1000 mL volume, 0.9% Sodium Chloride concentration, manufacturer Baxter (Shanghai) Co., Ltd., and spaces for lot, manufacturing, and expiration dates.*

FDA Label Image

Dhcp Letter 6.jpg (Image 06)

A comparative data table outlining key differences between FDA-approved 5% Dextrose Injection USP and imported 5% Glucose Injection from Shanghai, China. It details product names, label volumes, label language, indications, active ingredients, additional information like pH and osmolarity, caloric content, storage conditions, container types, and medication port closure features with small product images.*

FDA Label Image

Dhcp Letter 7.jpg (Image 07)

A data table comparing label images of FDA-approved 5% Dextrose Injection USP and imported 5% Glucose Injection from Shanghai, China. The table includes two representative 1000 mL labels with product names, concentration, and regulatory details, showing differences in layout, text, and barcode placement between the FDA-approved and imported labels.*

FDA Label Image

Dhcp Letter 8.jpg (Image 08)

A data table comparing key differences between FDA-approved 10% Dextrose Injection USP and an imported 10% Glucose Injection from Shanghai, China. The table covers product name, label volume, label language, indications, active ingredients, additional information (pH and osmolarity), caloric content, storage conditions, container type, and medication and administration port closures with illustrative images of port closures.*

FDA Label Image

Dhcp Letter 9.jpg (Image 09)

A comparative table showing label images of FDA-approved 10% Dextrose Injection USP and an imported 10% Glucose Injection from Shanghai, China. The labels feature black text, volume markings (50, 100, 150, 200 mL), product names, and additional product and manufacturer information including lot numbers, expiration dates, and instructions.*

FDA Label Image

Dhcp Letter 10.jpg (Image 10)

A comparative data table showing key differences between FDA-approved 5% Dextrose/0.9% Sodium Chloride Injection USP and imported 5% Glucose/0.9% Sodium Chloride Injection from Shanghai, China. The table covers product name, label volume, label language, indications, active ingredients, additional information including pH and osmolarity, caloric content, storage conditions, container types, and administration port closures with images of port protectors.*

FDA Label Image

Dhcp Letter 11.jpg (Image 11)

Packaging labels for 5% Dextrose and 0.9% Sodium Chloride Injection USP by Baxter Healthcare Corporation and an imported 5% Glucose and 0.9% Sodium Chloride Injection product from Shanghai, China. The FDA-approved label shows black text on a white background with dosage 1000 mL and usage instructions. The imported label includes similar information with manufacturer details, dosage, and barcode area indicated.*

FDA Label Image

Sodium Chloride A6c1322us Respresentative Container Label.jpg (Image 12)

Sodium Chloride Injection 0.9% 250 mL intravenous solution by Baxter Healthcare Corporation. The label states the solution is clear and colorless, with a strength equivalent to 2.25 g per 250 mL. It includes storage instructions and manufacturer details for Baxter Healthcare (Shanghai) Co., Ltd.*

FDA Label Image

Sodium Chloride A6c1323us Representative Container Label.jpg (Image 13jpg)

Sodium Chloride Injection 0.9% 500 mL intravenous solution label by Baxter Healthcare Corporation. The label indicates a clear, colorless liquid with 4.5g sodium chloride per 500 mL. It includes storage instructions, manufacturer details from Baxter Healthcare (Shanghai) Co., Ltd., and space for lot, manufacture date, and expiration date information.*

FDA Label Image

Sodium Chloride A6c1324us Representative Container Label.jpg (Image 14)

Label for Sodium Chloride Injection 0.9% solution, 1000 mL intravenous injection by Baxter Healthcare Corporation. The label indicates the concentration as 9 g per 1000 mL clear, colorless liquid, with storage instructions and directions for use included in text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.